Michelle B. Titunick, Ph.D.
Department of Medical Sciences
Dr. Titunick teaches gross anatomy, histology, and embryology at the Hackensack Meridian School of Medicine. Her research focuses on fracture repair in diabetes with a special interest in cell proliferation, vascularization, and mechanical strength. Dr. Titunick is also heavily involved in the IHS IPE Research Seminar Series.
- Ph.D., The Pennsylvania State University College of Medicine
- B.A., Rutgers University
- Titunick MB, Lewis GS, Cain JD, Zagon IS, McLaughlin PJ. “Blockade of the OGF-OGFr pathway in diabetic bone.” Connect Tissue Res. 2019 Nov;60(6):521-529. PubMed PMID: 30931654.
- McLaughlin PJ, Sassani JW, Titunick MB, Zagon IS. “Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.” BMC Ophthalmol. 2019 Jan 28;19(1):35. PubMed PMID: 30691415; PubMed Central PMCID: PMC6348650.
- McLaughlin PJ, Cain JD, Titunick MB, Sassani JW, Zagon IS. “Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.” Adv Wound Care (New Rochelle). 2017 Sep 1;6(9):279-288. PubMed PMID: 28894635; PubMed Central PMCID: PMC5592845.
- Stockdale DP, Titunick MB, Biegler JM, Reed JL, Hartung AM, Wiemer DF, McLaughlin PJ, Neighbors JD. “Selective opioid growth factor receptor antagonists based on a stilbene isostere.” Bioorg Med Chem. 2017 Aug 15;25(16):4464-4474. PubMed PMID: 28693915; PubMed Central PMCID: PMC5567982.